Production (Stage)
Biohaven Ltd.
BHVN
$15.06
-$0.28-1.83%
NYSE
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 33.98M | 22.46M | 20.56M | 18.95M | 27.27M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 221.56M | 179.03M | 178.17M | 333.77M | 183.24M |
| Operating Income | -221.56M | -179.03M | -178.17M | -333.77M | -183.24M |
| Income Before Tax | -221.07M | -186.80M | -160.36M | -319.59M | -178.94M |
| Income Tax Expenses | 609.00K | 48.00K | -59.00K | 177.00K | 569.00K |
| Earnings from Continuing Operations | -221.68M | -186.84M | -160.30M | -319.77M | -179.50M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -221.68M | -186.84M | -160.30M | -319.77M | -179.50M |
| EBIT | -221.56M | -179.03M | -178.17M | -333.77M | -183.24M |
| EBITDA | -219.32M | -176.57M | -176.17M | -331.82M | -181.79M |
| EPS Basic | -2.17 | -1.85 | -1.70 | -3.64 | -2.20 |
| Normalized Basic EPS | -1.38 | -1.13 | -1.10 | -2.31 | -1.40 |
| EPS Diluted | -2.17 | -1.85 | -1.70 | -3.64 | -2.20 |
| Normalized Diluted EPS | -1.38 | -1.13 | -1.10 | -2.31 | -1.40 |
| Average Basic Shares Outstanding | 101.94M | 101.05M | 94.37M | 87.77M | 81.60M |
| Average Diluted Shares Outstanding | 101.94M | 101.05M | 94.37M | 87.77M | 81.60M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |